# Bristol Myers Squibb Co: Form 8-K, filed Feb 5, 2026

- Company: [Bristol Myers Squibb Co](/companies/bmy.md) (CIK 14272)
- Form: 8-K
- Filed: 2026-02-05
- Accepted by EDGAR: Feb 5, 2026, 07:07 ET
- Period: 2026-02-05
- Accession: 0000014272-26-000002
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/14272/000001427226000002/bmy-20260205.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/14272/000001427226000002/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/14272/000001427226000002/bmy-20260205.htm

Filed Feb 5, 2026.
Source: SEC EDGAR, the filing index for accession 0000014272-26-000002. Last ingested by Listed: Oct 29, 2026, 11:17 ET. No prices; not investment advice.